Columbus McKinnon

CMCO · NASDAQ

$14.40−$0.20 (−1.37%)TodayMarket closed · Oct 20, 7:32 PM ET

Prev close $14.60

CMCO analyst rating

BuyConsensus of 2 analysts over the last 12 months. 50% rate it a buy.

Strong buy0
Buy1
Hold1
Underperform0
Sell0

12-month price target · 6 analysts

Average $25.50 (+77.1% upside)

Low: $18.18
Now: $14.40
High: $31.50

Upgrades and downgrades

The latest rating actions, newest first

CMCO analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
JP Morgan	Jul 31, 2026	Maintains	Overweight	$25.00 → $29.00	0%
DA Davidson	Jun 15, 2026	Maintains	Neutral	$20.00 → $17.00	49%
DA Davidson	Jun 5, 2026	Maintains	Neutral	$20.00	49%
JP Morgan	Feb 18, 2026	Maintains	Overweight	$29.00 → $27.00	0%
DA Davidson	Feb 12, 2026	Maintains	Neutral	$15.00 → $20.00	49%
DA Davidson	Feb 10, 2026	Maintains	Neutral	$15.00	49%

The case for and against

Updated Oct 18, 2026

Bull case

Columbus McKinnon is supported by a stronger order and backlog profile, with F4Q26 orders of $443M, a 1.01x book-to-bill, and backlog of $520M, up 61% Y/Y and including $200M from KitoCrosby. The outlook is further reinforced by encouraging order growth through the first 2 months of FY27, robust quotation activity in the U.S., and healthy demand in automation and lifting, even as EMEA remains pressured by geopolitical conflict and slower project conversion. FY27 guidance also signals confidence, with net sales of $2.05B-$2.12B, adj. EBITDA of $390M-$410M, and adj. EPS of $1.70-$1.90, though margin pressure from a 250bp gross margin decline to 32.7% remains a key watchpoint.

Bear case

Columbus McKinnon is viewed negatively because its short-cycle business offers limited visibility, while disruptions in the Middle East, COVID-19-related manufacturing and supply chain issues, and competition from lower-cost Asian crane and hoist makers can pressure revenue consistency and margins. Although F4Q26 revenue of $438M and adjusted EBITDA of $69M were roughly in line, adjusted EPS of $0.24 missed expectations, and the gap highlights how acquired intangibles amortization, weaker gross profit, and only partially offsetting cost controls can weigh on profitability. The outlook is further clouded by ~40% non-U.S. sales exposure to FX headwinds, partially hedged variable-rate debt amid rising rates, and FY27 guidance of $1.70-$1.90 EPS that still leaves execution risks around Monterrey, cost savings, and transformative M&A.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.